Description
BACTERIAL ID & SUSCEPTIBILITY TESTING
First action · last action
2026-05-08 · 2026-05-08
Transactions
1
First transaction's obligation
$195,666
Base + all options value (sum of deltas)
$195,666
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I))
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
36C24226A0027
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-05-08+$195,666= $195,666
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-05-08 | +$195,666 | $195,666 | BACTERIAL ID & SUSCEPTIBILITY TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HCNVCMEG9NL6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926F0276 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $60,940 | FY2026 |
| 36C25726N0441 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $122,631 | FY2026 |
| 36C25726D0091 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $0 | FY2026 |
| 36C26226N0903 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $67,946 | FY2026 |
| 36C24926N0666 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $982,841 | FY2026 |
| 36C24126N0842 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $310,739 | FY2026 |
Other recipients under 6550 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24226N0602 | ORTHO-CLINICAL DIAGNOSTICS, INC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $326,624 | FY2026 |
| 36C24226N0439 | ABBOTT MOLECULAR INC. | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $1,481,077 | FY2026 |
| 36C24226N0470 | ROCHE DIAGNOSTICS CORPORATION | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $280,841 | FY2026 |
| 36C24226N0386 | ABBOTT LABORATORIES INC. | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $160,972 | FY2026 |
| 36C24226N0364 | ABBOTT LABORATORIES INC. | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $54,701 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24226N0478_3600_36C24226A0027_3600 · retrieved 2026-09-26.